מדינה: קנדה
שפה: אנגלית
מקור: Health Canada
ATORVASTATIN (ATORVASTATIN CALCIUM)
PHARMARIS CANADA INC
C10AA05
ATORVASTATIN
10MG
TABLET
ATORVASTATIN (ATORVASTATIN CALCIUM) 10MG
ORAL
15G/50G
Prescription
HMG-COA REDUCTASE INHIBITORS
Active ingredient group (AIG) number: 0133055001; AHFS:
APPROVED
2021-10-22
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR PRZ-ATORVASTATIN Atorvastatin calcium tablets Tablets, 10 mg, 20 mg, 40 mg and 80 mg atorvastatin (as atorvastatin calcium), Oral USP LIPID METABOLISM REGULATOR Pharmaris Canada Inc. 8310-130 Street, Suite 102 Surrey, British Columbia Canada, V3W 8J9 Date of Initial Authorization: OCT 22, 2021 Date of Revision: FEB 15, 2023 Submission Control No: 268085 _ PRZ-ATORVASTATIN (atorvastatin calcium) _ _ _ _Page 2 of 64 _ RECENT MAJOR LABEL CHANGES 7 Warnings and Precautions, Musculoskeletal 02/2023 TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES............................................................................................. 2 TABLE OF CONTENTS ............................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION....................................................................... 4 1 INDICATIONS ..................................................................................................................... 4 1.1 Pediatrics............................................................................................................ 4 1.2 Geriatrics ............................................................................................................ 5 2 CONTRAINDICATIONS ........................................................................................................ 5 4 DOSAGE AND ADMINISTRATION........................................................................................ 5 4.1 Dosing Considerations ........................................................................................ 5 4.2 Recommended Dose and Dosage Adjustment ..................................................... 6 4.4 Administration .................................................................................................... 8 4.5 Missed dose ......................... קרא את המסמך השלם